Diasome Pharmaceuticals

Diasome Pharmaceuticals is a clinical-stage diabetes treatment company that designs and develops insulin-based therapies for diabetes treatment in the United States. The company's products include oral HVD-I, an oral insulin targeting pill or gel capsule formulations; HDV-I, an injectable short-acting insulin; and HDV-B, an injectable long-acting basal insulin. It develops products for patients with type 1 and type 2 diabetes.